Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India | Zendy

Vidya Madhavan | Zendy; Shanmugam Saravanan | Zendy; Uma Shanmugasundaram | Zendy; Nagalingeswaran Kumarasamy | Zendy; Solomon S Sunil | Zendy; Rami Kantor | Zendy; David Katzenstein | Zendy; Bharat Ramratnam | Zendy; Kenneth H. Mayer | Zendy; Solomon Suniti | Zendy; Pachamuthu Balakrishnan | Zendy

Open Access

Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India

Author(s) -

Vidya Madhavan,

Shanmugam Saravanan,

Uma Shanmugasundaram,

Nagalingeswaran Kumarasamy,

Solomon S Sunil,

Rami Kantor,

David Katzenstein,

Bharat Ramratnam,

Kenneth H. Mayer,

Solomon Suniti,

Pachamuthu Balakrishnan

Publication year - 2008

Publication title -

antiviral therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.747

H-Index - 87

eISSN - 2040-2058

pISSN - 1359-6535

DOI - 10.3851/imp1411

Subject(s) - medicine , resistance mutation , drug resistance , interquartile range , reverse transcriptase inhibitor , viral load , hiv drug resistance , reverse transcriptase , genotyping , nevirapine , exact test , immunology , gastroenterology , antiretroviral therapy , human immunodeficiency virus (hiv) , genotype , biology , polymerase chain reaction , biochemistry , gene , microbiology and biotechnology

HIV type-1 (HIV-1) monitoring in resource-limited settings relies on clinical and immunological assessment. The objective of this study was to study the frequency and pattern of reverse transcriptase (RT) drug resistance among patients with immunological failure (IF) to first-line therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research